Evidence map›Paper›PMID 33780557›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2021

Position statement of the EADV Melanoma Task Force on recommendations for the management of cutaneous melanoma patients during COVID-19.

M Arenbergerova, A Lallas, E Nagore, L Rudnicka, A M Forsea, M Pasek, F Meier, K Peris, J Olah, C Posch

Open access · bronzeAbstract readLetterConsensus Statement
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Impact of the COVID-19 Pandemic on Melanoma Diagnosis in Romania-Data from Two University Centers.International journal of environmental research and public health · 2022
    Article
  4. Melanoma care during one year pandemic in Berlin: decreasing appointment cancellations despite increasing COVID-19 concern.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2022
    Article
  5. Melanomversorgung während eines Jahres Pandemie in Berlin: abnehmende Terminstornierungen trotz zunehmender Besorgnis über COVID-19.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2022
    Article
  6. Article
  7. Review
  8. Review
  9. The impact of the COVID-19 pandemic on diagnostic delay of skin cancer: a call to restart screening activities.Journal of the European Academy of Dermatology and Venereology : JEADV · 2021
    Article
  10. Impact of the COVID-19 pandemic on melanoma diagnosis.Journal of the European Academy of Dermatology and Venereology : JEADV · 2021
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 10 countries.

M ArenbergerovaDepartment of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic.
A LallasFirst Department of Dermatology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.ORCID https://orcid.org/0000-0002-7193-0964
E NagoreDepartment of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain.ORCID https://orcid.org/0000-0003-3433-8707
L RudnickaDepartment of Dermatology, Medical University of Warsaw, Warsaw, Poland.ORCID https://orcid.org/0000-0002-8308-1023
A M ForseaCarol Davila University of Medicine and Pharmacy Bucharest, Bucharest, Romania.ORCID https://orcid.org/0000-0002-1007-7883
M PasekDepartment of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic.
F MeierSkin Cancer Center at the University Cancer Centre Dresden and National Center for Tumor Diseases, Dresden, Germany.
K PerisUOC di Dermatologia, Università Cattolica del Sacro Cuore, Rome, Italy.ORCID https://orcid.org/0000-0003-1957-6600
J OlahDepartment of Oncotherapy, Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary.
C PoschDepartment of Dermatology and Allergy, School of Medicine, German Cancer Consortium (DKTK), Technical University of Munich, Munich, Germany.ORCID https://orcid.org/0000-0003-0296-3567
Charles University · CZAristotle University of Thessaloniki · GRCarol Davila University of Medicine and Pharmacy · ROMedical University of Warsaw · PLNational Center for Tumor Diseases · DESigmund Freud Privatuniversität Wien · ATUniversità Cattolica del Sacro Cuore · ITUniversity of Szeged · HUValencia Catholic University Saint Vincent Martyr · ES

Funding

Charles University, Prague, Czech Republic PROGRES Q28
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19MelanomaSkin NeoplasmsHumansSARS-CoV-2

Identifiers

PMID33780557
PMCPMC8251426
OpenAlexW3144064296

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.